Latest news and press releases about ProPhase Labs, Inc. (PRPH): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
ProPhase Labs, Inc., founded in 1989 in Garden City, New York (and previously known as The Quigley Corporation), operates as a diversified company with two main areas of focus: Consumer Products and Diagnostic Services.
Price
| Price | $0.01 |
| Market Cap | $0M |
| Exchange | OTC |
| Country | US |
Valuation Ratios
| Price / Book | -0.06 |
| EV / EBITDA | -1.31 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -1358.66% |
| Return on Invested Capital | -188.35% |
| Return on Assets | -39.44% |
| Gross Margin | 16.38% |
| Operating Margin | -498.73% |
| Net Margin | -717.43% |
Related companies: ADAP · AEMD · ALUR · AYTU · BFRI · CODX · ERNA
Explore sector: Healthcare · Medical - Pharmaceuticals
More sections of PRPH: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks